This Orphan Drug Designation from the USFDA underlines the urgent medical need to develop a therapy for sickle cell disease
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
Under the agreement, Apotex’s branded division, Searchlight Pharma, will seek regulatory approval and handle marketing and distribution in Canada
Immunology remained AbbVie’s largest and fastest-growing segment, delivering $30.41 billion in global net revenues,
N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway
_Limited_256_384.jpg)
A PRV is a tradable voucher granted by the FDA to encourage the development of new treatments for rare pediatric diseases
The approved Lacosamide Oral Solution is bioequivalent and therapeutically equivalent to the reference drug and will be manufactured at Indoco’s facility in Verna Industrial Area, Goa
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Subscribe To Our Newsletter & Stay Updated
